🔎 Trials Near Me

Beranda › Glomerulonefritis IgA › Texas

Uji klinis Glomerulonefritis IgA di Texas

9 studi untuk Glomerulonefritis IgA mencari peserta di lokasi di Texas.

Kota di Texas

Teks studi resmi (Bahasa Inggris)

A Study to Learn About the Effects of Felzartamab Infusions on Adults With Immunoglobulin A Nephropathy (IgAN)

  • Texas Kidney Institute - Dallas, Dallas
  • Provecta Research Network, Houston
  • R & H Clinical Research, Katy
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Sep 2026 · NCT06935357

A Study of JADE101 in Participants With Immunoglobulin A Nephropathy

  • Jade Clinical Site, Houston
Menerima pesertaFase 2
Usia 18 hingga 60 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07541287

Phase 2 Study of ADX-038 in Complement-Mediated Kidney Disease

  • ADARx Clinical Site, Houston
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06989359

Open-label Extension Study of Zigakibart in Adults With IgA Nephropathy.

  • Dallas Renal Group, Dallas
  • Dallas Renal Group, Dallas
  • Nephro Asso North Illinois Indiana, Houston
Menerima pesertaFase 3
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT06858319

Study of WAL0921 in Patients With Glomerular Kidney Diseases

  • Prolato Clinical Research Center, Houston
  • Clinical Trial Network, Houston
  • Clinical Advancement Center, San Antonio
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 3 Agu 2026 · NCT06466135

Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN

  • Prolato Clinical Research Center, Houston
Menerima pesertaFase 2
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 29 Jul 2026 · NCT06797518

Study of BHV-1400 in IgA Nephropathy

  • Site-014, Houston
  • Site-004, Houston
Menerima pesertaFase 1
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 23 Jun 2026 · NCT07054684

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

  • Texas Children's Hospital, Houston
Menerima pesertaFase 2
Usia 1 hingga 17 · Semua jenis kelamin · Diperbarui 12 Mei 2026 · NCT05003986

Trial of the Impact of Sibeprenlimab on Immunoglobulin A Nephropathy Kidney Tissue

  • Clinical Research Site 324, Houston
Menerima pesertaFase 2
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 6 Apr 2025 · NCT06740526

Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.